A rationale for fractionation for slowly proliferating tumors such as prostatic adenocarcinoma
- 15 May 1995
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 32 (2) , 521-529
- https://doi.org/10.1016/0360-3016(95)00545-a
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Steepness of dose-response curve for larynx cancerRadiotherapy and Oncology, 1994
- Linear regressive analysis using prostate-specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancerCancer, 1993
- Preliminary results of a hyperfractionated dose escalation study for locally advanced adenocarcinoma of the prostateRadiotherapy and Oncology, 1993
- Cell Proliferation in Prostatic Adenocarcinoma: In Vitro Measurement by 5-Bromodeoxyuridine Incorporation and Proliferating Cell Nuclear Antigen ExpressionJournal of Urology, 1993
- Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: Results from the EORTC cooperative trial 22851Seminars in Radiation Oncology, 1992
- Brief summary of radiobiological principles in fractionated radiotherapySeminars in Radiation Oncology, 1992
- The effect of overall treatment time in radiotherapy for localized prostate carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1991
- The effect of overall treatment time on local control in patients with adenocarcinoma of the prostate treated with radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1990
- The linear-quadratic formula and progress in fractionated radiotherapyThe British Journal of Radiology, 1989
- A method to measure the duration of DNA syntheses and the potential doubling time from a single sampleCytometry, 1985